Avanos Medical Inc (NYSE: AVNS): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

AVNS belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. The current market capitalization of Avanos Medical Inc is $561.47M. A total of 0.56 million shares were traded on the day, compared to an average of 610.14K shares.

In the most recent transaction, BLACKFORD GARY bought 40,000 shares of AVNS for 10.99 per share on Aug 13 ’25. After the transaction, the Director now owns 40,000 company shares. In a previous transaction on Aug 13 ’25, BLACKFORD GARY bought 20,000 shares at 10.97 per share. AVNS shares that Director owns now total 91,593.

Among the insiders who sold shares, Holbrook Kerr disposed of 7,000 shares on Mar 06 ’25 at a per-share price of $15.25. This resulted in the SVP, Chief Commercial Officer holding 82,047 shares of AVNS after the transaction. In another insider transaction, Holbrook Kerr bought 7,000 shares at $15.25 per share on Mar 06 ’25.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, AVNS has a high of $24.23 and a low of $9.30.

As of this writing, AVNS has an earnings estimate of $0.12 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.12 per share and a lower estimate of $0.12. The company reported an EPS of $0.36 in the last quarter

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AVNS’s latest balance sheet shows that the firm has $118.50M in Cash & Short Term Investments as of fiscal 2021. There were $187.50M in debt and $139.20M in liabilities at the time. Its Book Value Per Share was $16.76, while its Total Shareholder’s Equity was $1.27B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AVNS is Buy with a score of 3.00.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.